Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep37 | Adrenal and Cardiovascular Endocrinology | ECE2020

Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia

Whitaker Martin J , Bonner Jennifer J , Burt Howard , Johnson Trevor N , Porter John , Ross Richard JM

Background: Replacing physiological cortisol levels is important for the long-term health of patients with adrenal insufficiency and congenital adrenal hyperplasia (CAH). Modified-release formulations of hydrocortisone are one strategy being used to replace the cortisol circadian rhythm in adult patients but there is no data in children. Physiologically based pharmacokinetic (PBPK) modelling is a valuable tool for paediatric drug development1; however, there are no ...

ea0070aep833 | Reproductive and Developmental Endocrinology | ECE2020

First in man study of oral native testosterone in hypogonadal men shows physiological testosterone levels in fed and fasted state

Newell-Price John , Porter John , Quirke Jo , Daniel Eleni , Mumdzic Enis , Ross Richard

Introduction: Current testosterone replacement therapies have limited acceptability: gels can be messy and risk inadvertent dosing of others; injections are painful; and oral testosterone undecanoate (TU) delivers variable testosterone levels, requires concurrent ingestion of a fatty meal and may produce supraphysiological dihydrotestosterone (DHT) levels1. We present the first human trial of an oral native testosterone preparation formulated to deliver testosterone...

ea0023oc6.3 | Oral Communications 6 | BSPED2009

Audit of paediatric diabetic eye screening

Dhillon Navpreet , Farnsworth Adele , Porter Lesley , Shaw Nick , Kirk Jeremy , Hoegler Wolfgang , Barrett Tim

Introduction: NICE recommends annual screening for diabetic retinopathy in children with type 1 diabetes aged over 12 years and/or with duration of diabetes over 5 years. This audit aimed to evaluate patient attendance for retinopathy screening, to identify the prevalence of retinopathy and maculopathy and to ascertain characteristics of patients.Methods: This was a retrospective audit of patients attending for eye screening from January 2008 to April 20...

ea0021p169 | Diabetes and metabolism | SFEBES2009

MOPDII and Alstrom syndrome: two centrosomopathies featuring severe insulin resistance and impaired adipogenesis

Huang-Doran Isabel , Porter Keith , O'Rahilly Stephen , Jackson Andrew , Semple Robert

Genetic defects in PCNT, encoding the centrosomal protein pericentrin, cause a rare syndrome of primordial dwarfism, skeletal dysplasia and facial dysmorphism, known as Majewski Osteodysplastic Primordial Dwarfism Type II (MOPDII). We now report that 11 out of 15 patients with PCNT defects had clinical and/or biochemical evidence of severe insulin resistance (IR), many also with severe dyslipidaemia; the remaining four were under 4 years-old. The metabolic profil...

ea0029p1238 | Obesity | ICEECE2012

Low dose 3-iodothyronamine increases acute lipolysis followed by protein catabolism in mouse

Chiellini G. , Assadi-Porter F. , Haviland J. , Butz D. , Reiland H. , Ghelardoni S. , Tonelli M. , Scanlan T. , Zucchi R.

3-iodothyronamine (T1AM) is a recently discovered fast-acting thyroid hormone derivative. To date, the physiological effects of endogenousT1AM remain elusive, although there is increasing interest in its physiological function and pharmaceutical potential due to the role it plays in lipid and glucose metabolism (1.2).The present study monitored the effect of weeklong, daily, low dose T1AM administration on weight and metabolism in spontaneously...

ea0024op1.4 | (1) | BSPED2010

Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes

Abid N , Buckley G , Porter L , Day E , Davies P , Shaw N , Kirk J , Krone N , Hogler W , Barrett T

Introduction: Two insulin regimes are commonly used in type 1 diabetes (T1D): twice daily (BD) premixed insulin (short and intermediate acting), and multiple daily injections (MDI) of short acting insulin with once daily bolus of long acting insulin. MDI is associated with better glucose control in adults, but the evidence base is weaker for children.Objectives: We aimed to compare children started on MDI to BD from diagnosis, on HbA1c as a measure of gl...

ea0021p170 | Diabetes and metabolism | SFEBES2009

A novel syndrome of IGF1 and insulin supersensitivity

Huang-Doran Isabel , Groeneveld Matthijs , Chandrasekera Hemantha , Porter Keith , O'Rahilly Stephen , McNulty Sid , Furlong Niall , Semple Robert

GH-secreting pituitary adenomas are by far the commonest cause of acromegalic soft tissue overgrowth. However the differential diagnosis includes pseudoacromegaly in rare patients with severe insulin resistance, with or without lipodystrophy, and some congenital overgrowth syndromes such as Sotos’ syndrome, due to mutations in the NSD1 gene. We now report the case of two siblings, born to non consanguinous, clinically unaffected Europid parents, with childhood over...

ea0010dp4 | Diabetes, metabolism and cardiovascular | SFE2005

Familial diabetes in Asian families; remember MODY

Porter J , Rangasami J , Ellard S , Gloyn A , Edwards J , Anderson J , Plunkett M , Shaw N , Frayling T , Hattersley A , Barrett T

Type 2 diabetes (T2DM) has emerged in youth, disproportionately affecting ethnic minorities. Maturity Onset Diabetes of the Young (MODY) has been reported in exclusively white UK children. We report the first UK Asian children with MODY, highlighting differences from T2DM.Child 1 is a slim (BMI SDS−0.14) female of Indian descent without acanthosis nigricans (AN). She presented aged 12 years with polydipsia and polyuria (HbA1c 8.6%). Hypoglycaemia w...

ea0073pep1.1 | Presented ePosters 1: Adrenal and Cardiovascular Endocrinology | ECE2021

Salivary steroid and 11‑oxygenated androgen profiles in patients with congenital adrenal hyperplasia on various glucocorticoid replacement regimens

Auer Matthias , Nowotny Hanna , Quinkler Marcus , Bidlingmaier Martin , Hawley James M , Adaway Jo , Keevil Brian , Ross Richard , Porter John , Reisch Nicole

Context11-oxygenated C19 steroids have recently gained attention as markers of androgen control in congenital adrenal hyperplasia (CAH) due to 21hydroxylase deficiency (21OHD). However, they have not yet been systematically investigated in the context of different glucocorticoid (GC) replacement regimens and in particular not in patients receiving new modified-release formulations.MethodsCross-sectional singl...